Evaluating the Maryland Cancer Collaborative A Measure of Progress, - - PowerPoint PPT Presentation

evaluating the maryland cancer collaborative a measure of
SMART_READER_LITE
LIVE PREVIEW

Evaluating the Maryland Cancer Collaborative A Measure of Progress, - - PowerPoint PPT Presentation

Evaluating the Maryland Cancer Collaborative A Measure of Progress, Successes, and Impact (2014-2019) Shilpa Gopinath, MPH Candidate Johns Hopkins Bloomberg School of Public Health Preceptors: Thuy Nguyen Health Educator Brian Mattingly


slide-1
SLIDE 1

Evaluating the Maryland Cancer Collaborative A Measure of Progress, Successes, and Impact (2014-2019)

Shilpa Gopinath, MPH Candidate Johns Hopkins Bloomberg School of Public Health

Preceptors:

  • Thuy Nguyen

Health Educator

  • Brian Mattingly

Program Director Maryland Department of Health

slide-2
SLIDE 2

Maryland Comprehensive Cancer Control Program (MCCCP)

 Established in1998  Addresses cancer prevention and control practices  Goal:

  • Decrease cancer incidence, morbidity and

mortality

  • Implement evidence-based strategies, support

cancer early detection efforts

  • Address the needs of cancer survivors; and

promote health equity

 Funded by the Centers for Disease Control and

Prevention (CDC)

The MCCCP operates on three main activities:

  • Maryland Cancer Collaborative (MCC)
  • Maryland Comprehensive Cancer Control Plan

(Cancer Plan)

  • Implementation Projects: Patient Navigation

Network (PNN)

slide-3
SLIDE 3

Maryland Cancer Collaborative (MCC)

MCC: Statewide cancer coalition. MCC is led by a Steering Committee of cancer control stakeholders, and its efforts are facilitated and supported by staff of the MCCCP. Goals of MCC:

  • Work with individuals and organizations

throughout the state to implement the MCCCP.

  • Bring together existing groups and new

partners from across the state to collaborate on a common goal - reducing the burden of cancer in Maryland.

slide-4
SLIDE 4

My Project

 Aim:

Evaluate the Maryland Cancer Collaborative in a five-year period (July 1, 2014 – June 30, 2019), its successes and challenges, its collective impact, and where it could have improved.

 Objective:

Produce an evaluation report by the end of the practicum to inform future MCC activities.

slide-5
SLIDE 5

Methods

 Met with MDH staff  Reviewed evaluation plan for health systems component of

MCC’s work to use as a model

 Reviewed key programdocuments  Evaluated potential datasources

Evaluation conducted using CDC evaluation framework

slide-6
SLIDE 6

Steps in the Evaluation Framework (as per CDC)

Source: Centers for Disease Control and Prevention. Framework for program evaluation in public health. MMWR 1999;48 (No. RR-11)

slide-7
SLIDE 7

Engaging Stakeholders

EVALUATION STAKEHOLDERS INVOLVEMENT IN THE EVALUATION WHAT STAKEHOLDERS WANT TO KNOW WHEN TO ENGAGE STAKEHOLDERS MDH’S CENTER FOR CANCER PREVENTION AND CONTROL LEADERSHIP Provide feedback on project evaluation Document the resources that have been leveraged to support program efforts All phases of the evaluation process PROGRAM STAFF

  • Provide information on the program

and coalitions

  • Provide input on evaluation, design,

data collection and interpretation of findings

  • Effective delivery of the program.
  • To what extent interventions outlined

in the cancer control plan are being executed and yielding intended results

  • How successful were the program’s

coalition All phases of the evaluation process CDC (FUNDER) Externally review the evaluation results.

  • Review the quality, contributions and

impact of the cancer control plan

  • Review the quality and

implementation progress of the statewide cancer control plan Dissemination phase

slide-8
SLIDE 8

Described MCC

 Provided narrative description of why the CDC provided funding, guidance, and technical

assistance to health agencies including MDH to launch the MCC.

 Described various components of the MCC in detail including the MCC’s logic model

(inputs, activities, outputs, outcomes, and impacts).

 Described the MCC, and its organization structure, workgroups, activities, and initiatives.  Described the stage of development and context.

slide-9
SLIDE 9

Evaluation Focus

Evaluation questions were selected and prioritized based on program needs Maryland Cancer Collaborative:  Were appropriate organizations represented on the MCC?  Were MCC members satisfied with activities and productivity?  Did MCC workgroups implement strategies of the Cancer Plan effectively?  Has the MCC built a strong partnership?

slide-10
SLIDE 10

FOCUS EVALUATION QUESTIONS INDICATORS DATA COLLECTION SOURCES DATA COLLECTION METHODS DATA ANALYSIS MARYLAND CANCER COLLABORATIVE MCC members:

  • Were appropriate
  • rganizations

represented on the coalition?

  • Were the MCC

members satisfied with activities and productivity?

  • How effective were the

workgroups in implementing strategies

  • f the MCC?
  • Has the MCC built a

strong partnership?

  • Number of members

and type of membership.

  • Extent to which

partners are satisfied.

  • Number of responses

from members to the annual member satisfaction survey.

  • Number of meetings

held.

  • Number of MCC

members reporting that they or their

  • rganization is

implementing the strategies.

  • Workgroup progress,

ex: completion of Action Plan and producing workgroup products. Program records (For example: committee updates, meeting minutes/schedule,

  • rganizational member

agreement forms, member satisfaction survey, annual evaluation reports) Extraction of data from program records including E-updates and meeting minutes, implementation reporting tools, member agreement forms, online surveys, annual evaluation reports

  • Percentage of members

in each organization, region and target group

  • Annual membership

survey completion engagement

  • Percentages of members

participating in meetings

  • ver time
  • Totals and percentages
  • f partners providing

various contributions

  • How effective was the

strategies implemented by the workgroups?

Outline of Evaluation Plan for Analysis and Interpretation

slide-11
SLIDE 11

Number of MCC Members

Source: 2014-19 MCC Evaluation Report

187 212 240 277 240 50 100 150 200 250 300 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 Number of MCC members

Evaluation Findings

slide-12
SLIDE 12

MCC Organizational Composition

Source: 2014-19 MCC Evaluation Report

33% 32% 37% 41% 43% 15% 20% 21% 17% 15% 15% 16% 13% 12% 14% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 Health Departments. Academic Institution

Hospitals

slide-13
SLIDE 13

MCC Race/Ethnicity Composition

59% 59% 58% 52% 47% 14% 14% 13% 13% 10% 6% 6% 5% 6% 4% 3% 3% 2% 2% 1% 3% 2% 1% 1% 1% 0% 1% 3% 3% 1% 13% 15% 18% 23% 36% 0% 10% 20% 30% 40% 50% 60% 70% FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 White Black/African American Asian or Pacific Islander Hispanic/Latino American Indian/Alaska Native Other Unknown

Source: 2014-19 MCC Evaluation Report

slide-14
SLIDE 14

MCC Geographic Representation

74% 71% 72% 69% 65% 3% 3% 4% 4% 2% 3% 3% 2% 2% 3% 1% 2% 3% 2% 3% 1% 2% 3% 3% 3% 14% 17% 14% 15% 15% 3% 3% 3% 5% 10% 0% 10% 20% 30% 40% 50% 60% 70% 80% FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 Baltimore Metro Eastern Maryland Eastern Shore Southern Maryland Western Maryland DC Metro Other

Source: 2014-19 MCC Evaluation reports

slide-15
SLIDE 15

MCC Member Satisfaction Survey Results

 Response rate in the last 5 years has ranged from 13% to 25%.  Respondents who were:

  • Very satisfied, satisfied, or somewhat satisfied with the Collaborative: 86% to 93%
  • Neither satisfied nor dissatisfied: 4% to 8%
  • Dissatisfied or very dissatisfied: none to 3%

 More than half of the respondents (54%-73%) have been with the

Collaborative for at least 2 years.

The top reasons why the respondents joined the Collaborative in the last 5 years:

  • Wanting to collaborate and network with other professionals/agencies/organizations.
  • Show their support for the Maryland Comprehensive Cancer Control Plan.
  • Work on cancer areas that they are most interested in/have the most expertise in.
  • Work on the implementation of the Cancer Plan and show support for the Cancer

Plan.

slide-16
SLIDE 16

MCC Workgroups

Survivorship Workgroup Develop and disseminate materials and explore the need/feasibility of providing formal training and/or certification to educate policy and decision makers about cancer survivorship including psychosocial issues and the role and value of providing long term care and support services to cancer survivors by 2015. Palliative Care Workgroup Develop an awareness campaign to educate Maryland citizens about palliative and hospice care, including pain management by 2015. Access to Care and Services Workgroup Reduce the burden of cancer in Maryland and reduce geographic and racial disparities in cancer incidence and mortality to reach the targets listed in the Cancer Plan by 2020.

slide-17
SLIDE 17

MCC Workgroups

Communications Workgroup Reduce the disparities in cancer incidence and mortality by 2020. Hospice Utilization Data Workgroup Develop and implement a process to collect Maryland- level data on hospice utilization by cancer patients and average length of stay for cancer patients. Tobacco Cessation Support to Providers Workgroup Provide healthcare providers with additional resources to aid in referring patients to individual, group, and/or telephone/web/text counseling.

slide-18
SLIDE 18

MCC Workgroups

HPV Vaccination Awareness Workgroup Increase awareness of HPV infection as a cancer risk factor among Maryland residents and implement systems changes within healthcare practices. Communications - Lesser Known Cancer Risk Factors Workgroup Increase awareness and educate the public about underappreciated and lesser known risk factors for cancer Cancer Survivorship Education Workgroup Educate cancer patients, their caregivers and providers about survivorship care plans and referral of patients to palliative or hospice care.

slide-19
SLIDE 19

MCC Annual Meeting

Primary purpose:

 Update MCC members on the burden of cancers in Maryland  Publicize the annual Maryland Comprehensive Cancer Control Plan and highlight

  • utstanding examples of how both the MCC and other organizations have

implemented the Cancer Plan.

 Present workgroups’ priority strategies and update workgroups’ progress

slide-20
SLIDE 20

Limitations/Challenges

 Data Collection &Feasibility  Program EvaluationCoursework

slide-21
SLIDE 21

Lessons Learned

 Improved my knowledgeof:  Public health practice in a state department of health  Qualitative methodologies in the real world, analytical, presentation,

and reporting skills, ability to multitask and manage time Programevaluation

slide-22
SLIDE 22

Conclusions – Implications for Policy & Practice

 Assess MCC’s current efforts to shape future

program activities

Evaluation plan can be used for recommendations and to shape decision-making related to the MCC program

Sharing and discussing evaluation results at future stakeholder meetings for prioritization and operationalization of recommendations for program improvement with stakeholders

 Identifying action steps staff members can take to

implement recommendations

slide-23
SLIDE 23

Acknowledgements

 Thanks to Thuy Nguyen, Brian Mattingly, and the rest of the MDH staff

that supported this project, as well as Beth Resnick, Paulani Mui, April Tong and Eril Smith at JHSPH.

slide-24
SLIDE 24

References

1. American Cancer Society, Cancer Facts and Figures 2019. Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer- facts-and-figures/2019/cancer-facts-and-figures-2019.pdf

  • 2. Maryland Comprehensive Cancer Control Plan 2016-2020. Retrieved

from http://ftp.cdc.gov/maryland_ccc_plan.pdf. 3. Framework for Program Evaluation - CDC. Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 15 May 2017. Retrieved from www.cdc.gov/eval/framework/index.html.

slide-25
SLIDE 25

Questions?